GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors
Year: 2024
Type: article
Study design: Observational Study
Source: JACC Heart Failure
Institutions: Lahey Hospital and Medical Center, Lahey Medical Center, Cleveland Clinic Akron General, University of California, Los Angeles, Saint Luke's Hospital, University of Missouri–Kansas City, Houston Methodist, Icahn School of Medicine at Mount Sinai, Brigham and Women's Hospital, University of Mississippi, Baylor Scott & White Research Institute
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: GLP-1 receptor agonists, SGLT2 inhibitors, heart failure with preserved ejection fraction, obesity, type 2 diabetes, heart failure hospitalization, heart failure exacerbation, emergency department visits, atrial arrhythmias, acute kidney injury, pulmonary hypertension, diabetic retinopathy, combination therapy, natriuretic peptides
Open Access status: bronze
OpenAlex ID: W4401944050
